Publication Details
| Pubmed | 15248757 |
| Title: | Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes. |
| Year: | 2004 |
| DOI: | https://doi.org/10.1021/bi049280b |
| First Author: | Reid |
| Experimental setup: | x-ray crystallography (IntAct) |
Interactions